Ghent University Academic Bibliography

Advanced

In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol.

Liping Pan and Frans Belpaire (1999) EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 55(8). p.599-604
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Eur. J. Clin. Pharmacol.
volume
55
issue
8
pages
599-604 pages
Web of Science type
Article
Web of Science id
000083338100008
ISSN
0031-6970
language
English
UGent publication?
yes
classification
A1
id
115513
handle
http://hdl.handle.net/1854/LU-115513
date created
2004-01-14 13:35:00
date last changed
2016-12-19 15:36:46
@article{115513,
  author       = {Pan, Liping and Belpaire, Frans},
  issn         = {0031-6970},
  journal      = {EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
  language     = {eng},
  number       = {8},
  pages        = {599--604},
  title        = {In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol.},
  volume       = {55},
  year         = {1999},
}

Chicago
Pan, Liping, and Frans Belpaire. 1999. “In Vitro Study on the Involvement of CYP1A2, CYP2D6 and CYP3A4 in the Metabolism of Haloperidol and Reduced Haloperidol.” European Journal of Clinical Pharmacology 55 (8): 599–604.
APA
Pan, L., & Belpaire, F. (1999). In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 55(8), 599–604.
Vancouver
1.
Pan L, Belpaire F. In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1999;55(8):599–604.
MLA
Pan, Liping, and Frans Belpaire. “In Vitro Study on the Involvement of CYP1A2, CYP2D6 and CYP3A4 in the Metabolism of Haloperidol and Reduced Haloperidol.” EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 55.8 (1999): 599–604. Print.